Chymopapain for herniated intervertebral disc. A methodologic analysis and an agenda for future research

Area of Science:

• Neurosurgery
• Pain Management
• Medical Device Research

Background:

• Chymopapain has gained US approval for chemonucleolysis, a procedure for herniated intervertebral discs.
• Emerging research necessitates robust evaluation criteria for clinicians and researchers.

Purpose of the Study:

• To establish criteria for assessing the validity and applicability of chemonucleolysis research.
• To identify common methodological flaws in existing studies.
• To propose improvements for future research designs.

Main Methods:

• A systematic review of 26 original articles on chemonucleolysis was conducted.
• Articles were evaluated based on nine criteria assessing study validity and applicability.
• Common threats to validity and applicability were identified.

Main Results:

• Key validity threats included lack of randomized controls, unblinded assessments, unequal co-treatments, and insufficient statistical power.
• Applicability issues stemmed from variations in patient selection, procedural techniques, and incomplete outcome reporting.
• Specific examples of methodological weaknesses were detailed.

Conclusions:

• Standardized criteria are essential for evaluating chemonucleolysis research.
• Addressing identified threats to validity and applicability will strengthen future investigations.
• A proposed study design aims to improve comparative research against surgical and conservative treatments.